可乐定结构式
|
常用名 | 可乐定 | 英文名 | Clonidine |
|---|---|---|---|---|
| CAS号 | 4205-90-7 | 分子量 | 230.094 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 319.3±52.0 °C at 760 mmHg | |
| 分子式 | C9H9Cl2N3 | 熔点 | 141-142℃ | |
| MSDS | N/A | 闪点 | 146.9±30.7 °C | |
| 符号 |
GHS06 |
信号词 | Danger |
可乐定用途Clonidine 是一种 alpha2- 肾上腺素能激动剂,被广泛应用于麻醉研究。 |
| 中文名 | 可乐定 |
|---|---|
| 英文名 | clonidine (amino form) |
| 中文别名 | 2-(2’,6’-二氯苯胺基)-2-咪唑啉 |
| 英文别名 | 更多 |
| 描述 | Clonidine 是一种 alpha2- 肾上腺素能激动剂,被广泛应用于麻醉研究。 |
|---|---|
| 相关类别 | |
| 靶点 |
alpha 2-adrenergic[1] |
| 体外研究 | 可乐定抑制神经元的放电活动[1]。 |
| 参考文献 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 沸点 | 319.3±52.0 °C at 760 mmHg |
| 熔点 | 141-142℃ |
| 分子式 | C9H9Cl2N3 |
| 分子量 | 230.094 |
| 闪点 | 146.9±30.7 °C |
| 精确质量 | 229.017349 |
| PSA | 36.42000 |
| LogP | 1.41 |
| 蒸汽压 | 0.0±0.7 mmHg at 25°C |
| 折射率 | 1.671 |
| 储存条件 | 库房通风低温干燥,轻装轻卸、与氧化剂和酸类分开存放 |
| 符号 |
GHS06 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H301 |
| 警示性声明 | Missing Phrase - N15.00950417 |
| 危害码 (欧洲) | F,T |
| 风险声明 (欧洲) | 11-23/24/25-39/23/24/25 |
| 安全声明 (欧洲) | 16-36/37-45 |
| 危险品运输编码 | UN 2811 6.1 / PGIII |
| 海关编码 | 2933290090 |
|
~%
可乐定 4205-90-7 |
| 文献：Chemie Linz Aktiengesellschaft Patent: US3988345 A1, 1976 ; |
|
~%
可乐定 4205-90-7 |
| 文献：Chemie Linz Aktiengesellschaft Patent: US3988345 A1, 1976 ; |
|
~%
可乐定 4205-90-7 |
| 文献：Chemie Linz Aktiengesellschaft Patent: US3988345 A1, 1976 ; |
|
~90%
可乐定 4205-90-7 |
| 文献：Mohanazadeh, Farajollah; Nami, Navabe; Hosseini, Samine Sadat Chinese Journal of Chemistry, 2011 , vol. 29, # 5 p. 1055 - 1058 |
| 海关编码 | 2933290090 |
|---|---|
| 中文概述 | 2933290090. 其他结构含非稠合咪唑环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Enteral absorption and haemodynamic response of clonidine in infants post-cardiac surgery.
Br. J. Anaesth. 113(6) , 964-9, (2014) Clonidine is a useful analgesic-sedative agent; however, few data exist regarding its use in infants after congenital heart disease surgery. We thus aimed to assess the absorption and safety of entera... |
|
|
Effect of severe acidosis on vasoactive effects of epinephrine and norepinephrine in human distal mammary artery.
J. Thorac. Cardiovasc. Surg. 147(5) , 1698-705, (2014) Acidosis is a very common pathologic process in perioperative management. However, how to correct severe acidosis to improve the efficacy of vasoconstrictors in hemodynamically unstable patients is st... |
|
|
Patient education and self-care for the management of jaw pain upon awakening: a randomized controlled clinical trial comparing the effectiveness of adding pharmacologic treatment with cyclobenzaprine or tizanidine.
J. Oral Facial Pain Headache 28(2) , 119-27, (2014) To compare the effectiveness of adding cyclobenzaprine, tizanidine, or placebo to patient education and a self-care management program for patients with myofascial pain and specifically presenting wit... |
| 2,6-Dichloro-N-(imidazolidin-2-ylidene)aniline |
| 1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- |
| Catapres-TTS |
| Catapresan |
| N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine |
| clonidine (amino form) |
| 2-(2',6'-dichlorophenylamino)-imidazoline |
| Catapressan |
| [3H]-Clonidine |
| Clonidin |
| 2,6-dichloro-N-imidazolidin-2-ylidèneaniline |
| Catarpres |
| Clonidine |
| Catarpresan |
| EINECS 224-119-4 |
| Adesipress |
| [14C]-Clonidine |
| Chlornidinum |
| 2,6-Dichlor-N-imidazolidin-2-ylidenanilin |
| Duraclon |
查看所有供应商和价格请点击：
CAS号33178-86-8